METTL1 and esophageal squamous cell carcinoma: It is confirmed that METTL1 overexpression in the ESCC cells is closely related to RPTOR/ULK1 axis, and it could be an effective strategy to treat METTL1 overactive ESCC by targeting mTOR/ULK1/autophagy signaling pathway100.